Information for medical professionals.
Please use the menu on the left to explore our resources for medical professionals. You can also click on the links below to view related articles. More information on surgical options can be found here.
American Medical Association policy statement on care for Care for Transgender Patients.
Use the menu to navigate more material in this section.
Guidelines for health organisations commissioning treatment services for trans people
Foreword by Lynne Jones MP
These guidelines have been produced by the Parliamentary Forum for Gender Identity to assist commissioners to make appropriate decisions in respect of providing funding for all aspects of the treatment required by people experiencing any degree of gender dysphoria. They are complementary to the Department of Health’s publication “Guidance for GPs, other clinicians and health professionals on the care of gender variant people”.
The Forum comprises Parliamentarians and the UK's leading experts on gender identity, in both the legal and medical fields, including Professor Kevan Wylie, Chair of the Committee set up by the Royal College of Psychiatrists in collaboration with the Royal College of Physicians and Surgeons and other colleges and societies to develop new standards of care for the treatment of trans people. Many of the leading advocates from the trans community also take part in our work, including those who have been instrumental in liaising with ministers and senior civil servants to bring about the successful passage and implementation of the Gender Recognition Act 2004.
I would like to acknowledge the work done to compile this document for the Forum by the Gender Identity Research and Education Society (GIRES).
The document may be dowloaded here.
WPATH Clarification
WPATH Clarification on Medical Necessity for Sex Reassignment Surgery Search the site.
The World Professional Association for Transgender Health has issued a ”Clarification on Medical Necessity for Sex Reassignment Surgery“. This is in response to questions about the medical necessity of transgender treatments and sex reassignment surgery, particularly in the U.S.A.,where insurance exclusions often prevent access to health care for transgender people. The WPATH Board of Directors has issued a clarification statement which is now available on the Resources page of the WPATH web site. Questions about this statement may be directed to the WPATH office, or to Mr. Jamison Green, Chair of the Public Policy, Advocacy & Liaison Committee of the Board. A parallel statement for international use (without the U.S. insurance focus, and reflecting ICD-10, to which the U.S.A. is not a signatory) is also under development. The clarification may be viewed here>.